Diagnosis of Alzheimer's disease: Two-decades of progress

Journal of Alzheimer's Disease

Volumn 9, Issue SUPPL. 3, 2006, Pages 409-415

  Khachaturian, Zaven S ^a  

^a NONE

Author keywords

Alzheimer's disease; Biomarkers; Dementia; Diagnosis; Diagnostic criteria; Diagnostic instruments; MCI; Mild cognitive impairments; National Institute on Aging; Neuroimaging; NIA; NIH

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; FOLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; VITAMIN;

AGING; ALZHEIMER DISEASE; BRAIN; CLINICAL RESEARCH; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DEMENTIA; HUMAN; NEUROIMAGING; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NEUROPROTECTION; PRIORITY JOURNAL; RATING SCALE; REVIEW;

EID: 33747386501     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/jad-2006-9s346     Document Type: Review

References (12)

1. Z.S. Khachaturian, Diagnosis of Alzheimer's disease, Arch Neurol 42(11) (1985), 1097-1105.
2. N.C. Berchtold and C.W. Cotman, Evolution in the conceptualization of dementia and Alzheimer's disease: Greco-Roman period to the 1960s, Neurobiol Aging 19(3) (1998), 173-189.
3. T.G. Beach, The history of Alzheimer's disease: three debates, J Hist Med Allied Sci 42(3) (1987), 327-349.
4. G. Blessed, B.E. Tomlinson and M. Roth, The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects, British Journal of Psychiatry 114 (1968), 797-811.
5. M.F. Folstein, S.E. Folstein and P.R. McHugh, Mini-Mental state. A practical method for grading the cognitive state of patients for the clinician, Journal of Psychiatric Research 12 (1975), 189-198.
6. W.G. Rosen, R.C. Mohs and K.L. Davis, A new rating scale for Alzheimer's disease, Am J Psychiatry 141(11) (1984), 1356-1364.
7. R. Katzman, Editorial: The prevalence and malignancy of Alzheimer disease. A major killer, Arch Neurol 33(4) (1976), 217-218.
8. Diagnostic and Statistical Manual of Mental Disorders. 1987. Third Edition-Revised. 3 ed. Washington, D.C.: American Psychiatric Association
9. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price and E.M. Stadlan, Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology 34(7) (1984), 939-944.
10. S. Mirra, A. Heyman, D. McKeel, S.M. Sumi, B.J. Crain, L.M. Brownlee et al., The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease, Neurology 41(4) (1991), 479-486.
11. R.C. Petersen, Mild cognitive impairment: transition between aging and Alzheimer's disease, Neurologia 15(3) (2000), 93-101.
12. Consensus Report of the Work Group, Molecular and Biochemical Markers of Alzheimer's Disease, The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Work Group, Neurobiol Aging 19 (1998), 109-116.